Peter L. Bonate

A Brief Introduction to Monte Carlo Simulation

Peter L. Bonate · Clinical Pharmacokinetics · 2001 · 235 citations

Business, Mathematics, Physics +12

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

Stefan Faderl, Varsha Gandhi, Susan O’Brien et al. · Blood · 2004 · 211 citations

Medicine, Oncology, Pharmacotherapy +10

Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

Manish A. Shah, Zev A. Wainberg, Daniel V.T. Catenacci et al. · PLoS ONE · 2013 · 206 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1

Elena Lukina, Nora Watman, Elsa Ávila Arreguin et al. · Blood · 2010 · 154 citations · Full text

Pharmacy, Pharmacotherapy, Oral Drug Delivery +3

Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi

Amit Desai, Laura Kovanda, Donna Kowalski et al. · Antimicrobial Agents and Chemotherapy · 2016 · 140 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +15